Why Do People Travel for Medical Care? Five Reasons That Go Beyond the Price Tag

People travel for medical care because their healthcare system has failed them in at least one of five ways: they can't get an appointment fast enough, they want a better clinical outcome, they're concerned about safety, the price is prohibitive, or nobody will coordinate their follow-up care. Most media coverage treats medical tourism as a cost story, and for American patients, cost is a significant factor. But a landmark McKinsey study of nearly 50,000 patients found that only 13% cited lower cost as their primary motivation. Seventy-two percent traveled for better technology and higher-quality care.

The gap between perception and reality matters because it changes how you evaluate your options. If you think this is purely about finding a cheaper doctor, you'll optimize for price and miss the factors that actually determine whether your experience goes well or badly.

Source: Ehrbeck, Guevara & Mango, McKinsey Quarterly, based on a survey of 49,980 patients.

1. The cost question is real, but it's not the whole story

For Americans specifically, cost carries more weight than it does for patients in countries with universal healthcare. A CDC population survey found that 51% of US medical tourists named cost as their primary reason for seeking treatment abroad, and another 14% said their insurance simply didn't cover what they needed. That tracks with broader coverage data. Twenty-three percent of working-age Americans with insurance were underinsured in 2024, according to the Commonwealth Fund's biennial health insurance survey, meaning their plans left them exposed to costs they genuinely could not absorb. When you're looking at a $30,000 dental implant bill or a $25,000 hair transplant that your insurer classifies as elective, a 60-80% savings abroad sounds less like tourism and more like basic math.

But cost is almost never the only factor that gets someone on the plane. The Medical Tourism Association's 2024 patient survey found that 97.2% of medical tourists ranked trust in their healthcare provider as the single most important factor in their decision. That is not a cost metric. Sixty-three percent said accreditation influenced their choice. And the top barriers that stopped prospective patients from following through weren't high prices at all. They were hidden costs, fear of complications, and poorly coordinated post-treatment care.

Cost opens the door. The other four reasons decide whether someone walks through it.

2. When the wait is measured in months, not weeks

The access problem looks different depending on where you live, but for a surprising number of patients in wealthy countries, it's the most urgent driver. In Canada, the median wait from a GP referral to treatment reached 28.6 weeks in 2025, per the Fraser Institute's annual "Waiting Your Turn" survey. That is not a typo. Half of all referred patients waited over six months. In New Brunswick, the figure climbed to nearly 61 weeks. Roughly 1.4 million Canadians were on a waiting list for a medical procedure that year.

Germany's two-tier insurance system creates its own access crisis. Patients on statutory insurance waited an average of 42 days for a specialist appointment in 2024, according to Federal Ministry of Health figures. But that average conceals enormous variation by specialty. Pulmonology patients waited 129 days. Dermatology averaged 84 days. Patients with private insurance were seen meaningfully faster, averaging closer to 35 days for the same specialist appointments. Dissatisfaction with specialist wait times among German patients has climbed noticeably over the past decade.

Then there are treatments that don't exist where you live. Regenerative medicine, certain stem cell therapies, and experimental protocols approved in some countries remain unavailable in others due to different regulatory frameworks. For patients with degenerative conditions who have exhausted conventional options, traveling for care is not about saving money or skipping a line. It's about reaching a treatment that their home country's approval process has not yet caught up to.

3. Outcomes, not just availability

The McKinsey finding that 72% of patients traveled for quality and technology becomes less surprising when you consider what a lower cost of labor enables clinically. A rehabilitation program at a top facility in Turkey or Thailand can staff three physiotherapists per patient during recovery. Outcomes get measured by functional milestones, like whether a knee replacement patient can climb stairs unassisted by day five, rather than just by whether the surgical wound looks clean at discharge. The labor economics that produce 60% savings for the patient simultaneously enable a depth of clinical attention that most Western hospitals cannot justify financially.

A study of medical tourism destination choice in Turkey found that quality of care and safety together influenced over 99% of patients' final decisions in path analysis, with quality of healthcare prioritized over cost. This aligns with what hair transplant researchers found when they broke down patient satisfaction into six distinct components: clinic and equipment quality, service quality, price-performance, transfer and accommodation, expectation fulfillment, and follow-up processes. Quality-related dimensions outnumbered cost-related ones by a factor of five to one.

None of this means every clinic abroad delivers superior outcomes. But the assumption that traveling for care means trading quality for savings is exactly backward for a significant majority of patients.

4. Safety is a two-layer problem

Safety functions as both a motivator and a barrier, sometimes simultaneously. The MTA's 2024 survey identified fear of complications as one of the top three barriers preventing prospective patients from following through. Yet safety also drives patients toward specific facilities that meet standards their local options may not.

The first layer is clinical: infection control, surgical protocols, equipment calibration, staff credentialing. Joint Commission International accreditation, which evaluates hundreds of criteria across patient safety and quality standards, remains the closest thing to a universal benchmark. More than 1,000 healthcare organizations in over 70 countries hold JCI accreditation as of 2025, and the updated 8th edition standards, effective January 1, 2025, added new requirements around environmental sustainability and health equity for the first time.

The second layer is something most patients don't think about until they're recovering: the destination environment itself. The CDC's Yellow Book addresses this directly, covering water quality, food safety, local sanitation, and infection risk during the days and weeks of post-operative healing. A sterile operating room doesn't help much if the hotel water makes you sick during recovery. This is where destination-level safety matters as well. A patient recovering from abdominal surgery needs to feel secure walking to a pharmacy, navigating transportation, and managing daily life while physically compromised.

Vetting processes that address both layers, not just checking credentials but evaluating the full recovery environment, separate platforms that genuinely understand medical travel from those that simply list clinics and leave you to figure out the rest.

5. Aftercare: the factor that separates good outcomes from regret

The fifth reason gets the least attention but may matter most. A German-led review of 17,543 medical tourists found that only one in three received any follow-up care after returning home. Over 80% reported zero information exchange between the international hospital and their home physician. The CDC is explicit about this gap: local follow-up care should be coordinated, and financing arranged, before you ever leave for treatment abroad.

The gap exists because the incentives don't align. Your surgeon abroad delivered a successful procedure and considers the case closed. Your primary care physician at home didn't choose the procedure, may not be familiar with the techniques used, and faces potential liability for managing someone else's surgical outcome. Some local providers decline to provide follow-up entirely. The CDC notes that patients have been "compelled to travel back to the clinic abroad for treatment" when complications arose and no domestic provider would take them on.

This is what makes the question of what happens after surgery so critical to ask before you go. A dental implant needs monitoring for months. A hair transplant requires growth-phase follow-up at 3, 6, and 12 months. A rhinoplasty patient needs someone tracking whether internal structures are healing symmetrically. Excellent surgery without coordinated aftercare is like buying a high-performance car with no maintenance plan. It might work out fine. But if it doesn't, the consequences compound quickly.

Some employers have figured this out before individual patients have. Ashley Furniture sent roughly 140 employees abroad for orthopedic procedures through a structured program with pre-arranged follow-up, zero out-of-pocket costs, and $5,000 in direct payments to each participant. The company saved approximately $3.2 million while employees reported high satisfaction because the aftercare coordination was built in, not bolted on. Forty-four percent of large employers now offer or plan to offer some form of medical travel benefit, according to a Mercer survey, though most still focus heavily on cost and underinvest in the aftercare infrastructure that actually determines outcomes.

What this means if you're weighing treatment abroad

The conventional framing of medical tourism as "fly somewhere cheap and save money" misses most of what drives the decision and nearly everything that determines the result. People travel because they can't access care fast enough, because outcomes available abroad genuinely match or exceed what they'd find at home for specific procedures, because accredited facilities meet safety standards they can verify, because the pricing is transparent and dramatically lower, and because the best programs coordinate aftercare so savings don't come at the cost of results.

If you're evaluating this decision, the five-reason framework matters more than any single factor. A company that only talks about savings understands one-fifth of the equation. Be especially skeptical of anyone who doesn't mention aftercare at all. That's where most experiences diverge between patients who rave about the decision and patients who regret it, and it's where the right support makes the biggest difference.